Pfizer 12 mai 2026 Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu - Fierce Pharma
Pfizer 12 mai 2026 BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial - Clinical Trials Arena
Pfizer 12 mai 2026 Pfizer Ltd stock (INE182A01018): Indian pharma subsidiary eyes growth - AD HOC NEWS
Pfizer 6 mai 2026 Cytospire’s backers buy in as Pfizer exits | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Pfizer 5 mai 2026 Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager - Fierce Biotech
Pfizer 5 mai 2026 FDA approves Pfizer and Arvina’s breast cancer drug despite weak clinical data - medwatch.com
Pfizer 4 mai 2026 Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - 24/7 Wall St.
Pfizer 4 mai 2026 Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo Finance
Pfizer 1 mai 2026 FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype - Fierce Pharma